You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Qiagen has submitted an offer to buy all of Exiqon's shares for DKK18 each, for a total aggregate purchase price of DKK683 million ($103.5 million).
In Nucleic Acids Research this week: atlas of microRNAs from various tissues types, ribosomal RNA gene flanking region sequencing, and more.
A new study by an international team of researchers has found that the microRNA miR-9-5p has a role in the development of schizophrenia.
The company sees microRNAs as the ideal blood-based biomarker for diagnosing and monitoring a number of diseases at the point of care and in the developing world.
In PNAS this week: single-stranded cytosine deamination in E. coli, characterization of herpes simplex virus-1 microRNAs, and more.
The test could provide an early diagnosis of breast cancer by examining a handful of miRNA, microRNA, and proteomic biomarkers from urine samples.
The companies will evaluate Diamir's technology as a potential companion diagnostic to certain Janssen neurodegenerative disease programs.
In PNAS this week: genetic and proteomic study of the type VII secretion system in tuberculosis, miRNA expression differences in social and solitary locusts, and more.
Researchers get a clear image of the DROSHA protein and gain a better understanding of the Microprocessor complex involved in miRNA biogenesis.
The researchers were able to differentiate among patients with lung cancer, COPD, and health controls using the biomarkers.
President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.
A study of Great Danes homes in on a genomic region linked to fearfulness.
CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.
In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.